No two women are exactly alike. No two breast cancers are exactly alike.
Accuray's patient-first innovations allow you to give every woman
the personalized treatment she deserves—minimizing side effects,
improving quality of life and helping drive superior outcomes.
© 2007 - 2017 Accuray Incorporated. All Rights Reserved. Accuray, the stylized logo, CyberKnife, TomoTherapy, Synchrony, Xsight, Xchange, TomoHD, Hi•Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.
Important Safety Statement: Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death.
Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient's general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.
The Radixact™ and TomoTherapy® Treatment Delivery Systems provide the flexibility to adapt radiation therapy to any breast cancer patient's anatomy, delivering optimal coverage to the target volumes with minimized cardiac
dose and organ-at-risk exposure.
Expanding treatment capabilities like no other system in the world.
Professor Roberto Orecchia
Scientific Director of the European Institute of Oncology